» Articles » PMID: 24951399

Kawasaki Disease is Associated with Sensorineural Hearing Loss: a Systematic Review

Overview
Specialty Pediatrics
Date 2014 Jun 22
PMID 24951399
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Context: Kawasaki Disease (KD), a systemic vasculitis of unknown etiology, has been associated with the development of sensorineural hearing loss (SNHL). KD is primarily a disease of young children, who are the most susceptible to complications from even minimal hearing loss. If there is a connection between KD and the development of SNHL, a better understanding of this relationship may improve our management of this disease and its complications.

Objective: To perform a systematic review according to a standardized guideline to evaluate the possible association between KD and SNHL.

Data Sources: Medline and PubMed online databases were reviewed for appropriate articles.

Study Selection: All studies available in English discussing KD and SNHL were included.

Data Extraction: Studies were assessed primarily for the incidence of SNHL. Where possible, they were assessed for the degree and laterality of the loss, length of follow up and change in hearing over time.

Results: 8 studies meeting the criteria were assessed. 3 were case reports, 1 was a case series and the remaining 4 were prospective control trials. 8 patients have been reported as cases, and 240 assessed in PCT. 36% of patients assessed had some degree of SNHL, and overall 14% had evidence of persistent SNHL at follow up.

Conclusions: This systematic review would suggest there is an association between KD and SNHL. It is important for physicians caring for patients with KD to be aware of this complication and consider screening these patients given possible complications of hearing loss in this age group.

Citing Articles

Case report: Cochlear implantation was effective for progressive bilateral severe hearing loss associated with Kawasaki disease.

Murakami D, Kimura T, Kono M, Sakai A, Suenaga T, Hiraoka M Front Pediatr. 2023; 11:1199240.

PMID: 37635798 PMC: 10448821. DOI: 10.3389/fped.2023.1199240.


Neurological manifestations of Kawasaki disease and multisystem inflammatory syndrome in children associated with COVID-19: A comparison of two different clinical entities.

Mauro A, Di Mari C, Casini F, Giani T, Sandini M, Biondi L Front Pediatr. 2023; 10:1088773.

PMID: 36683824 PMC: 9849814. DOI: 10.3389/fped.2022.1088773.


Clinical Manifestations and Laboratory Findings of Kawasaki Disease: Beyond the Classic Diagnostic Features.

Lee W, Cheah C, Suhaini S, Azidin A, Khoo M, Ismail N Medicina (Kaunas). 2022; 58(6).

PMID: 35743997 PMC: 9227912. DOI: 10.3390/medicina58060734.


Impact of Early Treatment With High-Dose Intravenous Immunoglobulin on Incidence of Kawasaki Disease Complications in Iranian Children.

Karimi Yazdi A, Akbariasbagh P, Aghighi Y, Raeeskarami S, Toomaj K, Heidari S J Family Reprod Health. 2022; 15(4):242-247.

PMID: 35340797 PMC: 8897822. DOI: 10.18502/jfrh.v15i4.7890.


Kawasaki Disease Complicated by Late-Onset Fatal Cerebral Infarction: A Case Report and Literature Review.

Wang L, Duan H, Zhou K, Hua Y, Liu X, Wang C Front Pediatr. 2021; 9:598867.

PMID: 34095019 PMC: 8170391. DOI: 10.3389/fped.2021.598867.